Buy PW Medtech for 3x upside in the long term with strong fundamentals. Added spice is the technicals support with William %R being in the oversold category!!
Dagangan aktif
More BUY signals! CBPO 3Q results were mindblowing!: Company's key subsidiary CBPO has reported blockbuster 3Q results: Revenue and Operating earnings went up 14% YoY and 85% YoY, respectively. This will be reported on PW Medtech's Net profit on next earning season! On annual basis, this is around US
37M annualized NP for PW Medtech. Company also made some sales of CBPO shares with total proceeds at US$101mn so it's net cash would be US$31M. Plus the company itself makes around US
6MN in annual OP. So, let's just say we are only going to count CBPO value (14% stake in listed CBPO stock) & US
31M in cash and giving 0 value to the parentco company. CBPO's market cap is US$4.4B and 13.9% of this equals $642m. This added with cash is US$673m.Let's say we give around 30% discount on this value which is US$436M. This is still 70% higher than current market price!!! Continue buying!
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.